Literature DB >> 26299276

Update on Hippocampal Sclerosis.

Juliana R Dutra1, Etty P Cortés, Jean Paul G Vonsattel.   

Abstract

The diagnostic hallmarks of hippocampal sclerosis (HS) are severe volume loss of the hippocampus, severe neuronal loss, and reactive gliosis involving primarily two especially vulnerable fields, CA1 and the subiculum. Occasionally, HS may be the only neuropathological change detected in older individuals with dementia and is known as pure HS. In the majority of cases, HS occurs in the setting of other degenerative changes, usually Alzheimer's disease (AD). In these cases, it is classified as combined HS. Although a clinical profile for HS has been identified, its similarities with AD make the diagnosis during life quite challenging; thus, the diagnosis is often made postmortem. The pathogenesis of HS is not completely understood, but the strong association with transactive response DNA-binding protein 43 (TDP-43), in approximately 90%, and the recent discovery of genetic risk factors are important contributions to a better understanding of the disease process.

Entities:  

Mesh:

Year:  2015        PMID: 26299276     DOI: 10.1007/s11910-015-0592-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  38 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

2.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease.

Authors:  Nicola J Rutherford; Minerva M Carrasquillo; Ma Li; Gina Bisceglio; Joshua Menke; Keith A Josephs; Joseph E Parisi; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin; Dennis W Dickson; Rosa Rademakers
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

4.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

5.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

6.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

7.  Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.

Authors:  James B Leverenz; Christina M Agustin; Debby Tsuang; Elaine R Peskind; Steven D Edland; David Nochlin; Lillian DiGiacomo; James D Bowen; Wayne C McCormick; Linda Teri; Murray A Raskind; Walter A Kukull; Eric B Larson
Journal:  Arch Neurol       Date:  2002-07

Review 8.  Hippocampal sclerosis dementia: a reappraisal.

Authors:  Alphonse Probst; Kirsten I Taylor; Markus Tolnay
Journal:  Acta Neuropathol       Date:  2007-07-17       Impact factor: 17.088

9.  Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.

Authors:  Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.

Authors:  Osamu Yokota; Yvonne Davidson; Eileen H Bigio; Hideki Ishizu; Seishi Terada; Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Stephen Sikkink; Stuart Pickering-Brown; David M A Mann
Journal:  Acta Neuropathol       Date:  2010-05-30       Impact factor: 17.088

View more
  11 in total

1.  Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.

Authors:  Peter T Nelson; Yuriko Katsumata; Kwangsik Nho; Sergey C Artiushin; Gregory A Jicha; Wang-Xia Wang; Erin L Abner; Andrew J Saykin; Walter A Kukull; David W Fardo
Journal:  Acta Neuropathol       Date:  2016-11-04       Impact factor: 17.088

2.  The Association Between Neurocysticercosis and Hippocampal Atrophy is Related to Age.

Authors:  Oscar H Del Brutto; Naoum P Issa; Perla Salgado; Victor J Del Brutto; Mauricio Zambrano; Julio Lama; Héctor H García
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

3.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

Review 4.  Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia.

Authors:  Gamze Balci Camsari; Melissa E Murray; Neill R Graff-Radford
Journal:  Neurol Clin       Date:  2016-06-03       Impact factor: 3.806

5.  Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.

Authors:  Kwangsik Nho; Andrew J Saykin; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 7.  Untangling tau imaging.

Authors:  Victor L Villemagne; Nobuyuki Okamura; Christopher C Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-04

8.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

9.  Hippocampal Malrotation Could Be Less Significant in Epilepsy Caused by Focal Cortical Dysplasia Type I and Type II.

Authors:  Chenmin He; Lingqi Ye; Cong Chen; Lingli Hu; Bo Jin; Yao Ding; Hong Li; Meiping Ding; Shan Wang; Shuang Wang
Journal:  Front Neurol       Date:  2022-02-14       Impact factor: 4.003

10.  Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study.

Authors:  Mia Kero; Anna Raunio; Tuomo Polvikoski; Pentti J Tienari; Anders Paetau; Liisa Myllykangas
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.